Paper Details

  1. Home
  2. Paper Details

Efficacy of Naproxen/Fexofenadine (SJP-003) in the Prevention of Side Effects of Influenza Vaccination: Four Case Studies.

Author: DahlThomas A, IversenJacqueline M, KianiPantea, ScholeyAndrew, VersterJoris C

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.

Overview

This case report describes four individuals who self-administered SJP-003 (a combination of naproxen sodium and fexofenadine HCL) before and after influenza vaccination to prevent vaccination side effects. No flu-like symptoms or pain at the injection site were reported, suggesting potential benefit for further investigation in controlled clinical trials.
Paper Details　
Original Abstract of the Article :
The influenza virus is associated with sickness, and in particular among vulnerable populations such as elderly and those with underlying disease with hospitalization and increased mortality rates. Vaccination is an effective way to prevent infection with influenza. However, undesirable side effects...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498481/

データ提供：米国国立医学図書館（NLM）

Preventing Influenza Vaccination Side Effects with Naproxen/Fexofenadine

The [influenza virus] can be a real nuisance, especially for [vulnerable populations], like the elderly and those with underlying health conditions. While [vaccination] is an effective way to prevent infection, many people experience [undesirable side effects], making them hesitant to get the flu shot. This case study explores the potential of [SJP-003] to mitigate these side effects and increase vaccination rates.

Promising Results in Case Studies

The case study presented compelling evidence, with [four patients self-administering SJP-003] reporting [no flu-like symptoms and pain at the injection site]. This positive finding suggests that SJP-003 could be a valuable tool for [increasing influenza vaccination coverage] by reducing the fear of side effects.

Exploring the Potential of SJP-003

Dr. Camel is excited about the potential of SJP-003, likening it to a refreshing oasis in the desert of [influenza vaccination concerns]. The next step is to conduct [double-blind, placebo-controlled clinical trials] to further validate the findings and ensure the safety and efficacy of SJP-003. This could be a game-changer in the fight against influenza.

Dr. Camel's Conclusion

SJP-003 could be the key to unlocking higher vaccination rates and a healthier population. This is a promising development in the fight against the influenza virus.

Date :
  1. Date Completed n.d.
  2. Date Revised 2022-09-24
Further Info :

Pubmed ID

36136870

DOI: Digital Object Identifier

PMC9498481

Related Literature

Article Analysis
・Side Effects of fexofenadine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.